Incidence of intussusception among infants in a large commercially insured population in the United States

Pediatric Infectious Disease Journal

Volumn 31, Issue 3, 2012, Pages 287-291

  Mona Eng, Patricia ^a   Mast, T Christopher ^b   Loughlin, Jeanne ^a   Clifford, C Robin ^a   Wong, Judy ^a   Seeger, John D ^a,c,d  

^a OPTUM   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

cohort study; epidemiology; health insurance claims; rotavirus

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; ROTAVIRUS VACCINE;

ARTICLE; EMERGENCY WARD; FEMALE; FOLLOW UP; HEALTH INSURANCE; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFANT; INFANT DISEASE; INTUSSUSCEPTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT DURATION; UNITED STATES; VACCINATION;

COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; INTUSSUSCEPTION; MALE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84857628589     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31824213b1     Document Type: Article

References (30)

1. Tucker A, Haddix A, Bresee J, Holman R, Parashar U, Glass R. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA. 1998;279:1371-1376.
2. Rotavirus vaccines. Wkly Epidemiol Rec. 2007;82:285-295.
3. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564-572. (Pubitemid 32167870)
4. Parashar UD, Alexander JP, Glass RI. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Policies (ACIP). MMWR. 2006;55:1-14.
5. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33. (Pubitemid 43048948)
6. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22. (Pubitemid 43048947)
7. Rosenthal S, Chen R. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health. 1995;85:1706-1709. (Pubitemid 26002609)
8. Mullooly J, Drew L, DeStefano F, et al. Quality of HMO vaccination databases used to monitor childhood vaccine safety. Vaccine Safety DataLink Team. Am J Epidemiol. 1999;149:186-194. (Pubitemid 29039522)
9. CDC. Postmarketing monitoring of intussusception after RotaTeq vaccination-United States, February 1, 2006-February 15, 2007. MMWR. 2007; 56:218-222.
10. Haber P, Patel M, Izurieta HS, et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006 to September 25, 2007. Pediatrics. 2008;121:1206-1212.
11. Parashar ID. Holman RC, Cummings KC, et al. Trends in intussusceptionassociated hospitalizations and deaths among US infants. Pediatrics. 2000; 106:1413-1421.
12. Simonsen L, Morens DM, Elixhauser A, et al. Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet. 2001;358:1224-1229. (Pubitemid 33010847)
13. Tate JE, Simonsen L, Viboud C, et al. Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring safety of the new rotavirus vaccination program. Pediatrics. 2008;121:e1125-e1132.
14. Fischer TK, Bihrmann K, Perch M, et al. Intussusception in early childhood: a cohort study of 1.7 million children. Pediatrics. 2004;114:782-785. (Pubitemid 41529539)
15. Chang HH, Smith PF, Ackelsberg J, et al. Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York State. Pediatrics. 2001;108:54-60. (Pubitemid 32592005)
16. Simonsen L, VIboud C, Elixhauser A, et al. More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis. 2005;192(suppl 1):S36-S43. (Pubitemid 41193100)
17. Cooke DC, Lewis EC. Thirty-year survey of acute intussusception in childhood. Lancet. 1960;7165:1359-1364.
18. Hutchison IR, Olayiwola C, Young DG. Intussusception in infancy and childhood. Br J Surg. 1980;67:209-212. (Pubitemid 10173936)
19. Tai JH, Curns AT, Parashar UD, et al. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule? Pediatrics. 2006;118: e258-e264. (Pubitemid 46085365)
20. Kramarz P, France EK, Destefano F, et al. Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis. 2001;20:410-416. (Pubitemid 32294750)
21. Staat MA, Roberts N, Bernstein DI. Epidemiology and clinical features of intussusception in children >24 months of age in Hamilton County, Ohio [abstract]. Pediatr Res. 2000;49:242A.
22. Bajaj L, Roback MG. Postreduction management of intussusception in a children's hospital emergency department. Pediatrics. 2003;112:1302-1307. (Pubitemid 37523411)
23. Centers for Disease Control and Prevention. Available at: http://www.cdc. gov/vaccines/recs/schedules/default.htm. Accessed June 25, 2008.
24. Seeger JD, Loughlin J, Eng PM, et al. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives. Obstet Gynecol. 2007;110:587-593. (Pubitemid 47359582)
25. Cole JA, Ephross SA, Cosmatos IS, et al. Paroxetine in the first trimester and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf. 2007;16:1075-1085. (Pubitemid 350020060)
26. McAfee AT, Koro C, Landon J, et al. Coronary heart disease outcomes in patients receiving antidiabetic agents. Pharmacoepidemiol Drug Saf. 2007; 16:711-725. (Pubitemid 47180361)
27. McAfee AT, Chilcott KE, Johannes CB, et al. The incidence of first provoked and unprovoked seizure in pediatric patients with and without psychiatric diagnoses. Epilepsia. 2007;48:1075-1082. (Pubitemid 46854885)
28. Johannes CB, Koro CE, Quinn SG, et al. The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy. Pharmacoepidemiol Drug Saf. 2007; 16:504-512. (Pubitemid 46824271)
29. Daly L. Simple SAS macros for the calculation of exact binomial and Poisson confidence limits. Comput Biol Med. 1992;22:351-361.
30. SAS/STAT Software, version 8.2. Cary, NC: SAS Institute Inc.